Stifel Financial’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37K Sell
83,088
-5,650
-6% -$4.29K ﹤0.01% 3593
2025
Q4
$116K Sell
88,738
-17,720
-17% -$28.4K ﹤0.01% 3473
2025
Q3
$150K Buy
106,458
+22,041
+26% +$67.2K ﹤0.01% 3395
2025
Q2
$377K Buy
84,417
+11,550
+16% +$52.1K ﹤0.01% 2930
2025
Q1
$333K Buy
72,867
+10,909
+18% +$60K ﹤0.01% 2918
2024
Q4
$377K Buy
61,958
+21,168
+52% +$144K ﹤0.01% 2846
2024
Q3
$321K Buy
40,790
+10,224
+33% +$103K ﹤0.01% 2925
2024
Q2
$343K Buy
30,566
+159
+0.5% +$1.86K ﹤0.01% 2845
2024
Q1
$385K Sell
30,407
-558
-2% -$7.35K ﹤0.01% 2754
2023
Q4
$425K Buy
30,965
+980
+3% +$11.5K ﹤0.01% 2659
2023
Q3
$339K Buy
29,985
+2,303
+8% +$27.6K ﹤0.01% 2722
2023
Q2
$370K Sell
27,682
-3,413
-11% -$40K ﹤0.01% 2711
2023
Q1
$361K Buy
+31,095
New +$366K ﹤0.01% 2697

Other funds holding BIOX

Stifel Financial's BIOX Position: Q1 2026 in Review

Stifel Financial reduced its Bioceres Crop Solutions (BIOX) stake by 6.4% in Q1 2026, selling an estimated $4.29K and leaving 83,088 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

Stifel Financial first reported a position in BIOX in Q1 2023 and has held it in 13 quarters since. The position peaked at $425K in Q4 2023. 32 funds tracked by Wall St. Rank hold BIOX as of Q1 2026.

  • Stifel Financial held 83,088 shares of Bioceres Crop Solutions worth $37K as of Q1 2026.
  • Stifel Financial sold 5,650 Bioceres Crop Solutions shares in Q1 2026, an estimated $4.29K.
  • Bioceres Crop Solutions made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3593 holding.
  • Stifel Financial first reported a position in Bioceres Crop Solutions in Q1 2023 and has held it in 13 quarters since.
  • Stifel Financial's Bioceres Crop Solutions position peaked at $425K in Q4 2023.
  • 32 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.